Immunogenicity of synthetic Rhodococcus equi virulence-associated protein peptides in neonate foals

International Journal of Medical Microbiology

Volumn 296, Issue 6, 2006, Pages 389-396

  Cauchard, Julien ^a   Taouji, Saïd ^a   Sevin, Corinne ^a   Duquesne, Fabien ^a   Bernabé, Magali ^a   Laugier, Claire ^a   Ballet, Jean Jacques ^b  

^a Healthy Pigs Production and Experimentation Section   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Foal; Horse; Immunization; Opsonization; Rhodococcus equi; Synthetic peptides

Indexed keywords

ARGINYLARGINYLSERYLASPARAGINYLVALYLISOLEUCYLTRYPTOPHANYLPROLYLVALYLSERYL LYSYLASPARTYLGLUTAMINYLLEUCYLLEUCYLARGININE; BACTERIAL PROTEIN; BACTERIAL VACCINE; CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; LYSYLALANYLALANYLISOLEUCYLPROLYLGLUTAMYLASPARTYLLYSYLGLUTAMYLTYROSYL ASPARTYLVALYLSERYLGLYCYLARGININE; OPSONIN; SYNTHETIC PEPTIDE; TYROSYLASPARAGINYLLEUCYLGLUTAMINYLLYSYLASPARTYLGLUTAMYLPROLYLASPARAGINYL GLYCYLARGINYLALANYLSERYLASPARTYLTHREONINE; TYROSYLASPARTYLPHENYLALANYLALANYLGLUTAMYLALANYLLYSYLSERYLGLYCYLSERYL SERYLISOLEUCYLPROLYLALANYLLYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FRANCE; HORSE; HYDROPHILICITY; IMMUNE RESPONSE; IMMUNOGENICITY; JAPAN; MOLECULAR RECOGNITION; NEWBORN; NONHUMAN; OPSONIZATION; RHODOCOCCUS EQUI; VACCINATION;

EID: 33748450761     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2006.02.020     Document Type: Article

References (39)

1. Byrne B.A., Prescott J.F., Palmer G.H., Takai S., Nicholson V.M., Alperin D.C., and Hines S.A. Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins. Infect. Immun. 69 (2001) 650-656
2. Calamel M., and Lambert M. ELISA Standardised Technique (1988), Laboratoire de Pathologie des Petits Ruminants, Nice, France
3. Cauchard J., Sevin C., Ballet J.J., and Taouji S. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet. Microbiol. 104 (2004) 73-81
4. Demmers S., Johannisson A., Grondahl G., and Jensen W. Neutrophil functions and serum IgG in growing foals. Equine Vet. J. 33 (2001) 676-680
5. Emini E.A., Hughes J.V., Perlow D.S., and Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J. Virol. 55 (1985) 836-839
6. Giguere S., and Prescott J.F. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet. Microbiol. 56 (1997) 313-334
7. Giguere S., Gaskin J.M., Miller C., and Bowman J.L. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J. Am. Vet. Med. Assoc. 220 (2002) 59-63
8. Giguere S., Jacks S., Roberts G.D., Hernandez J., Long M.T., and Ellis C. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J. Vet. Intern. Med. 18 (2004) 568-573
9. Grondahl G., Johannisson A., and Jensen W. Opsonic effect of equine plasma from different donors. Vet. Microbiol. 56 (1997) 227-235
10. Harvey R.L., and Sunstrum J.C. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis. 13 (1991) 139-145
11. Hietala S.K., and Ardans A.A. Neutrophil phagocytic and serum opsonic response of the foal to Corynebacterium equi. Vet. Immunol. Immunopathol. 14 (1987) 279-294
12. Hooper-McGrevy K.E., Giguere S., Wilkie B.N., and Prescott J.F. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Am. J. Vet. Res. 62 (2001) 1307-1313
13. Hooper-McGrevy K.E., Wilkie B.N., and Prescott J.F. Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins. Clin. Diagn. Lab. Immunol. 10 (2003) 345-351
14. Hopp T.P., and Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78 (1981) 3824-3828
15. Jameson B.A., and Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput. Appl. Biosci. 4 (1988) 181-186
16. Kanaly S.T., Hines S.A., and Palmer G.H. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 63 (1995) 3037-3041
17. Kanaly S.T., Hines S.A., and Palmer G.H. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 64 (1996) 1126-1132
18. Kyte J., and Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157 (1982) 105-132
19. Lopez A.M., Hines M.T., Palmer G.H., Alperin D.C., and Hines S.A. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab. Immunol. 9 (2002) 1270-1276
20. Lunn D.P., and Townsend H.G. Equine vaccination. Vet. Clin. North Am. Equine Pract. 16 (2000) 199-226
21. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R.J., Macklin M.D., McCabe D.E., Swain W.F., and Olsen C.W. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 17 (1999) 2245-2258
22. Madigan J.E., Hietala S., and Muller N. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J. Reprod. Fertil. 44 (1991) 571-578
23. Martens R.J., Martens J.G., Renshaw H.W., and Hietala S.K. Rhodococcus equi: equine neutrophil chemiluminescent and bactericidal responses to opsonizing antibody. Vet. Microbiol. 14 (1987) 277-286
24. Martens R.J., Martens J.G., Fiske R.A., and Hietala S.K. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet. J. 21 (1989) 249-255
25. Meijer W.G., and Prescott J.F. Rhodococcus equi. Vet. Res. 35 (2004) 383-396
26. Morein B., Villacres-Eriksson M., Ekstrom J., Hu K., Behboudi S., and Lovgren-Bengtsson K. ISCOM: a delivery system for neonates and for mucosal administration. Adv. Vet. Med. 41 (1999) 405-413
27. Prescott J.F. Rhodococcus equi: an animal and human pathogen. Clin. Microbiol. Rev. 4 (1991) 20-34
28. Prescott J.F., and Hoffman A.M. Rhodococcus equi. Vet. Clin. North Am. Equine Pract. 9 (1993) 375-384
29. Prescott J.F., Nicholson V.M., Patterson M.C., Zandona Meleiro M.C., Caterino D.A., Yager J.A., and Holmes M.A. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia. Am. J. Vet. Res. 58 (1997) 356-359
30. Prescott J.F., Patterson M.C., Nicholson V.M., Morein B., and Yager J.A. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein VapA in mice. Vet. Microbiol. 56 (1997) 213-225
31. Ribeiro M.G., Seki I., Yasuoka K., Kakuda T., Sasaki Y., Tsubaki S., and Takai S. Molecular epidemiology of virulent Rhodococcus equi from foals in Brazil: virulence plasmids of 85-kb type I, 87-kb type I, and a new variant, 87-kb type III. Comp. Immunol. Microbiol. Infect. Dis. 28 (2005) 53-61
32. Takai S., Koike K., Ohbushi S., Izumi C., and Tsubaki S. Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J. Clin. Microbiol. 29 (1991) 439-443
33. Takai S., Takeda K., Nakano Y., Karasawa T., Furugoori J., Sasaki Y., Tsubaki S., Higuchi T., Anzai T., Wada R., and Kamada M. Emergence of rifampin-resistant Rhodococcus equi in an infected foal. J. Clin. Microbiol. 35 (1997) 1904-1908
34. Takai S., Shoda M., Sasaki Y., Tsubaki S., Fortier G., Pronost S., Rahal K., Becu T., Begg A., Browning G., Nicholson V.M., and Prescott J.F. Restriction fragment length polymorphisms of virulence plasmids in Rhodococcus equi. J. Clin. Microbiol. 37 (1999) 3417-3420
35. Taouji S., Breard E., Peyret-Lacombe A., Pronost S., Fortier G., and Collobert-Laugier C. Serum and mucosal antibodies of infected foals recognized two distinct epitopes of VapA of Rhodococcus equi. FEMS Immunol. Med. Microbiol. 34 (2002) 299-306
36. Taouji S., Nomura I., Giguere S., Tomomitsu S., Kakuda T., Ganne V., and Takai S. Immunogenecity [sic!] of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi. Vaccine 22 (2004) 1114-1123
37. Vanniasinkam T., Barton M.D., and Heuzenroeder M.W. B-Cell epitope mapping of the VapA protein of Rhodococcus equi: implications for early detection of R. equi disease in foals. J. Clin. Microbiol. 39 (2001) 1633-1637
38. Varga J., Fodor L., Rusvai M., Soos I., and Makrai L. Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines. Vet. Microbiol. 56 (1997) 205-212
39. Wilson W.D., Mihalyi J.E., Hussey S., and Lunn D.P. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet. J. 33 (2001) 644-650